Drinking coffee or tea may be beneficial for physical function in ageing   

18 Feb 2025

2nd APIC-ADVA Summit: To Drive Discussions on Infectious Diseases and Immunization In the Era of Polycrises

The Asia Pacific Immunization Coalition (APIC) and the Asia Dengue Voice & Action (ADVA), in collaboration with the Centre for Behavioural and Implementation Science Interventions (BISI) at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), convened the 2nd APIC-ADVA Summit from 11 February to 13 February 2025.

Read More

18 Feb 2025

NUS Medicine pioneers ground-breaking technique to deliver drugs directly to the brain

Scientists at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have developed a ground-breaking technique to deliver therapeutic molecules directly to the brain, bypassing the blood-brain barrier. Led by Dr Haosheng Shen, lead researcher from the Synthetic Biology Translational Research Programme, NUS Medicine and the NUS Synthetic Biology for Clinical and Technological Innovation (SynCTI) this novel approach utilises a naturally occurring nasal bacterium, Lactobacillus plantarum (Lp), which was genetically engineered to produce therapeutic compounds and release them through a specific nose-to-brain pathway. Their research was published in leading life sciences journal, Cell.

Read More

12 Feb 2025

NUS Medicine study: Inability of cells to recycle fats can spell disease

Accumulation of fat molecules is detrimental to the cell. Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have made a breakthrough in understanding how our cells manage to stay healthy by recycling important fat molecules. Their study, published in the journal Proceedings of the National Academy of Sciences (PNAS), reveals how a protein called Spinster homolog 1 (Spns1) helps transport fats out of cell compartments known as lysosomes.

Read More

11 Feb 2025

NUS Medicine launches new centre to bolster global pandemic preparedness and response to infectious disease emergencies

NUS Medicine announced the official launch of the Centre for Infectious Disease Emergency Response (CIDER) on 10 February 2025, an innovative initiative aimed at enhancing pandemic preparedness and strengthening responses to infectious disease emergencies. The launch was attended by over 15 ambassadors and other country representatives.

Read More

04 Feb 2025

Metastatic cancers: How targeting a protein that fuels treatment-resistant tumours may be key to better outcomes

One of the biggest challenges in cancer treatment is addressing the ability of cancer cells to adapt and become resistant, reducing the effectiveness of therapies over time. While treatments like chemotherapy or targeted therapies may initially shrink tumours, they often lose their effectiveness after a period. This resistance often emerges in metastatic tumours, because cancer cells can evolve in ways that allow them to survive, such as developing new ways to communicate with one another.

Read More

28 Jan 2025

Transforming longevity research: AI paves the way for personalised treatments in ageing science

A collaborative study between researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), and the Institute for Biostatistics and Informatics in Medicine and Ageing Research, Rostock University Medical Center, Germany and published in the leading review journal Ageing Research Reviews investigated how advanced AI tools, like Large Language Models (LLMs), can make it easier to evaluate interventions for ageing and provide personalised recommendations.

Read More

23 Jan 2025

NTU Singapore’s TARIPH Centre leads multi-institution research programme with first national research grant for lung health

Read More

21 Jan 2025

Shorter, Smarter, Safer: Short-course antibiotics can revolutionise healthcare

Antibiotic overuse is a key driver in the rise of antimicrobial resistance (AMR), a major global health crisis. Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Duke-NUS Medical School have provided compelling evidence that short-course antibiotic treatments can be a game-changer in tackling ventilator-associated pneumonia (VAP), a serious infection common in critically ill patients.

Read More

15 Jan 2025

NUS Medicine study discovers potential for new colorectal cancer treatment

Colorectal cancer (CRC) is a type of cancer that begins in the colon (large intestine) or rectum, which are parts of the digestive system. It typically starts as abnormal growths called polyps that form in the lining of the colon or rectum. Over time, some of these polyps can become cancerous if left untreated. CRC is one of the most common cancers in Singapore, with an average of about 2,540 cases a year, and it is also one of the top cancers contributing to cancer mortality in Singapore. It is the third most common cancer worldwide, accounting for approximately 10% of all cancer cases according to the reports from World Health Organization (WHO). Issues including cancer recurrence and development of drug resistance pose a significant challenge in CRC treatment, highlighting the need for new therapeutic methods.

Read More

13 Jan 2025

NUS Medicine study: Brain connectome phenotype linked to cerebrovascular disease can track cognitive decline

Researchers have uncovered novel insights into how brain function disruptions related to cerebrovascular disease (CeVD) interact with Alzheimer’s disease (AD) pathology to impact neurodegeneration and cognition in older adults. Led by Associate Professor Juan Helen Zhou, Director of the Centre for Translational Magnetic Resonance Research, Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), the research team revealed a brain functional connectome phenotype that is related to multiple CeVD markers and contributes additively to cognitive decline and neurodegeneration alongside AD. The study highlights CeVD as a global disruptor of brain connectivity, reshaping our understanding of its role in dementia.

Read More